Pseudolymphoma, a challenge for dermatopathology
Keywords:
PSEUDOLYMPHOMA, IMMUNOHISTOCHEMISTRY.Abstract
Introduction: pseudolymphoma is a rare and generally idiopathic disease, constituting a group of benign dermatoses with a histologic picture that hardly distinguishes it from lymphomas. They can be divided into two main groups according to the predominant lymphocyte (T or B) in the infiltrates and their clinical presentation varies according to the stimuli that provoke the disease.
Objective: to describe a patient with a cutaneous pseudolymphoma treated at the Oncology Service of the General Teaching Hospital Abel Santamaría Cuadrado of Pinar del Río.
Case presentation: female patient, white, 66 years old, hypertensive, who was registered in the Oncology service on March 9, 2020 because she presented brown skin lesions predominantly in the lower limbs. She was evaluated by the dermatology department who suspected a cutaneous lymphoma and conducted a systematic diagnosis which concluded in cutaneous B-cell lymphoid hyperplasia.
Conclusions: pseudolymphoma can have a very varied clinical presentation and many factors can trigger its appearance. A systematic diagnosis including interrogation, physical examination, histology and immunohistochemistry is essential. The use of steroids is effective for the treatment of the skin lesion and subsequent follow-up by dermatology is insisted upon.
Downloads
References
1. Caravanti NC, Vendrame CB, de Aguiar BS. Hiperplasia linfoide cutánea de patrón reaccional (Pseudolinfoma) Presentación de caso. Revista Corpus Hippocraticum [Internet]. 2019 [Citado 26/07/2022]; 1(1). Disponible en: https://revistas.unilago.edu.br/index.php/revista-medicina/article/view/155/129
2. Bracho-Villalobos GA, Rivas AK, Pérez HG. Pseudolinfoma cutáneo a propósito de ocho casos clínicos e histopatológicos. Revista del Colegio de Médicos Veterinarios del Estado Lara [Internet]. 2018 [Citado 26/07/2022]; 15(8). Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7782002
3. Blanco Falette DM, Vidal Brioso PM, Cruz Rodríguez GM. Reporte de caso: linfocitoma cutis. Diagnóstico-Tratamiento-Evolución. Ciencia y Salud [Internet]. 9 de junio de 2021 [Citado 26/07/2022]; 5(2): 155-57. Disponible en: https://revistas.intec.edu.do/index.php/cisa/article/view/2215
4. Mitteldorf C, Kempf W. Cutaneous pseudolymphoma. SurgPatholClin [Internet]. 2017 [Citado 26/07/2022]; 10(2): 455-76. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1875918117300156
5. Cattani G, Florian AB, Solva EW, et al. Linfocitoma cutis localizado: presentación de caso. Hematology, transfusión and cell therapy [Internet]. Oct 2021 [Citado 26/07/2022]; 43(sup.1). Disponible en: https://www.sciencedirect.com/science/article/pii/S2531137921002753
6. Borges-Costa J, Seixas J, Soares de Almeida L, Kutzner H. Nódulos cutaneous eritematosos emdoente residente na África Austral: pseudolinfoma. Revista SPDV [Internet]. 2020 [Citado 21/08/2022]; 78(2): 158-164. Disponible en: https://core.ac.uk/download/pdf/335291117.pdf
7. Vargas Gutiérrez S, Ramos Valdés JR, Martín Pozo Y. Plasmocitosis cutánea, forma infrecuente de pseudolnfoma cutáneo. Informe de caso. Acta méd centro [Internet]. 2022 Mar [Citado 21/08/2022]; 16(1): 158-164. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2709-79272022000100158
8. Ruiz Matta JM, Vázquez Ramírez M, Puebla Miranda M, Cuesta Mejías T, Gálvez Juárez YA. Foliculitispseudolinfomatosa: reporte de caso. Dermatología CMQ [Internet]. 2020 [Citado 21/08/2022]; 18(2): 111-114. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2020/dcm202h.pdf
9. Cabrera HN, Casas JG, Griffa E, Sorgentini C. Foliculitis pseudolinfomatosa de McNutt (localización nasal). Dermatología argentina [Internet]. Julio-Septiembre de 2021 [Citado 21/08/2022]; 27(3): 111-114. Disponible en: https://www.dermatolarg.org.ar/index.php/dermatolarg/article/view/2187/1204
10. Vicente Cid A. Reacciones cutáneas adversas en tatuajes decorativos: presentación de 9 casos y revisión de la literatura.Trabajo de Fin de Grado [Tesis]. Universidade de Santiago de Compostela. Facultade de Medicina e Odontoloxía; 2020 [Citado 21/08/2022]. Disponible en: https://dspace.usc.es/xmlui/handle/10347/24846
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
